2020
DOI: 10.1002/ajmg.a.61598
|View full text |Cite
|
Sign up to set email alerts
|

Shortfall of exome analysis for diagnosis of Shwachman‐Diamond syndrome: Mismapping due to the pseudogene SBDSP1

Abstract: Shwachman-Diamond syndrome characterized by metaphyseal dysplasia, pancreatic insufficiency, and pancytopenia is caused by biallelic mutations in SBDS. Gene conversion between SBDS and its pseudogene SBDSP1 is the major cause. Here, we report two unrelated patients with Shwachman-Diamond syndrome who were shown to be compound heterozygotes for relatively frequent pathogenic alleles (the 258+2T>C allele and another allele composed of 183-184TA>CT and 201A>G) using an established polymerase chain reaction sequen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
15
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(15 citation statements)
references
References 11 publications
0
15
0
Order By: Relevance
“…Yamada et al reported two SDS patients with compound heterozygous mutations in the SBDS gene (c.258+2T>C on one allele and c.183_184delinsCT together with c.201A>G on the other), validated by Sanger sequencing. However, the c.183_184delinsCT and c.201A>G variants were not identified by whole-exome sequencing (WES) in either patient due to mismapped reads, which pointed out the shortcomings of NGS data analysis for SDS diagnosis [22] . Since SDS usually presents with clinical heterogeneity and is thought to be underdiagnosed in the general population [12] , the omittance of pathogenic variants limited by ambiguous read mapping during conventional NGS analysis might be one of the possible causes.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…Yamada et al reported two SDS patients with compound heterozygous mutations in the SBDS gene (c.258+2T>C on one allele and c.183_184delinsCT together with c.201A>G on the other), validated by Sanger sequencing. However, the c.183_184delinsCT and c.201A>G variants were not identified by whole-exome sequencing (WES) in either patient due to mismapped reads, which pointed out the shortcomings of NGS data analysis for SDS diagnosis [22] . Since SDS usually presents with clinical heterogeneity and is thought to be underdiagnosed in the general population [12] , the omittance of pathogenic variants limited by ambiguous read mapping during conventional NGS analysis might be one of the possible causes.…”
Section: Introductionmentioning
confidence: 99%
“…Disentangling the disease-causing variants through short NGS reads is frequently limited since SBDS shares 97% identity with SBDSP1 [21][22][23] . Yamada et al reported two SDS patients with compound heterozygous mutations in the SBDS gene (c.258+2T>C on one allele and c.183_184delinsCT together with c.201A>G on the other), validated by Sanger sequencing.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…[12][13][14][15] Sequencing analysis may miss mutations in SBDS due to large deletions or difficulties with the highly homologous pseudogene, so further evaluation should be pursued when clinical suspicion is high. 16,17 SDS registries in France and Italy recently reported characteristics of severe cytopenias, clonal cytogenetic abnormalities, and malignancies in patients with biallelic SBDS mutations. The French Neutropenia Registry, which included 102 patients with biallelic SBDS mutations, reported a 20-year cumulative risk of both non-malignant and malignant severe cytopenias of 24.3%.…”
Section: Introductionmentioning
confidence: 99%
“…Since the common SBDS pathogenic variants c.185_184TA>GT and c.258+2T>C are at the functional PSV loci, it has been suggested that recombination and gene conversion might occur between SBDS and SBDSP1 [11] . Based on the above factors, researchers have recognized the complexity and challenges of NGS analysis of the SBDS gene, and therefore suggest using PCR, RT-PCR or specific bioinformatics tools to increase the sensitivity and specificity of detecting pathogenic variants in SBDS [12][13][14] .…”
Section: Introductionmentioning
confidence: 99%